FAST NEWS: Biotech Startup Sciwind Lands $70 Million in New Funding
The latest: Biotech startup Hangzhou Sciwind Biosciences Co. Ltd. announced it has closed its third funding round, raising 450 million yuan ($70 million). New backers in the latest round included…
RELATED ARTICLES
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
- InSilico seeks IPO boost to get AI drugs over the line
-
Cash-strapped Viva Biotech sells stake and plans spinoff
1873.HK
- Funding boost gets Sunho Biologics over the IPO filing line
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Drug maker Junshi seeks Swiss cure for cash woes
1877.HK 688150.SHG
- ProfoundBio discovers the joys of having a wealthy owner
Discover hidden China stock gems in our weekly newsletter